Heparin Sodium Wockhardt Uk (Heparin Sodium)

Heparin Sodium Wockhardt Uk is used in clinical settings to prevent and treat thromboembolic conditions where rapid anticoagulation is required.

• Prevention and treatment of deep vein thrombosis (DVT) in hospitalized or immobile patients.
• Prevention and treatment of pulmonary embolism (PE) following surgery or trauma.
• Anticoagulation during cardiac, vascular, or cardiopulmonary bypass procedures.
• Maintenance of circuit patency in extracorporeal dialysis or hemofiltration systems.
• Prophylaxis of clot formation in patients with atrial fibrillation undergoing invasive procedures.
• Adjunctive anticoagulation in patients receiving thrombolytic therapy for acute myocardial infarction.

Heparin Sodium Wockhardt Uk may be associated with a range of adverse effects, which are generally categorized by frequency and clinical significance.

Common

• Minor bleeding at the injection site or from mucous membranes.
• Small bruising (ecchymosis) in areas of venipuncture.
• Transient elevation of liver enzymes.
• Nausea or mild gastrointestinal discomfort.
• Transient low platelet count without clinical significance.
• Mild headache or dizziness.

Serious

• Major hemorrhage, including intracranial or gastrointestinal bleeding.
• Heparin‑induced thrombocytopenia (HIT) with a rapid drop in platelet count.
• Allergic reactions such as rash, itching, or anaphylaxis.
• Spinal or epidural hematoma when used in neuraxial procedures.
• Acute adrenal insufficiency due to bilateral adrenal hemorrhage.

When prescribing Heparin Sodium Wockhardt Uk, clinicians should evaluate patient‑specific factors and monitor for conditions that increase bleeding risk.

• Assess baseline coagulation parameters (aPTT, PT/INR) before initiation.
• Review history of heparin‑induced thrombocytopenia or other heparin allergies.
• Use caution in patients with active gastrointestinal ulcers, recent surgery, or intracranial lesions.
• Adjust dose or avoid use in severe renal or hepatic impairment.
• Monitor platelet counts regularly to detect HIT early.
• Avoid concurrent use with other anticoagulants or antiplatelet agents unless medically justified.
• Consider pregnancy status, as safety data are limited.

Heparin Sodium Wockhardt Uk can interact with several medications, influencing anticoagulant effect or bleeding risk.

Avoid

• Concurrent use with other parenteral anticoagulants such as low‑molecular‑weight heparin or direct thrombin inhibitors.
• Combination with potent antiplatelet agents (e.g., clopidogrel, ticagrelor) without close monitoring.
• Co‑administration with fibrinolytic drugs (e.g., alteplase, streptokinase) due to heightened hemorrhagic potential.

Use with caution

• Non‑steroidal anti‑inflammatory drugs (NSAIDs) and aspirin may increase minor bleeding; monitor gastrointestinal tolerance.
• Certain antibiotics (e.g., vancomycin, cefazolin) can alter platelet function; observe for signs of HIT.
• Herbal supplements such as ginkgo biloba, garlic, or high‑dose vitamin E may potentiate anticoagulation; assess patient use.